IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.17 -0.64 (-1.69%)
As of: Oct 2, 2026 · 11:24 AM EDT

IDEAYA Biosciences (IDYA) Accumulated Expenses (2018 - 2026)

Updated

IDEAYA Biosciences (IDYA) posted Accumulated Expenses of $50.98 million for Q2 2026, up 35.0% from $37.75 million a year earlier and up 16.5% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, IDEAYA Biosciences' Accumulated Expenses came in at $40.89 million, up 34.7% from FY2024.

  • Annual Accumulated Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
  • In prior years, IDEAYA Biosciences' Accumulated Expenses was $30.35 million in FY2024 (+61.8%), $18.76 million in FY2023 (+10.3%), $17 million in FY2022 (+38.0%) and $12.32 million in FY2021 (+44.7%).
  • The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2018.
  • On a year-over-year basis, Accumulated Expenses has increased in each of the last 11 quarters, with growth averaging 55.3% over the last eight quarters.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2025, with growth of 87.8%; the weakest was Q2 2023, with a decline of 9.5%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $43.75 million (Q1 2026), $40.89 million (Q4 2025) and $45.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 IDEAYA Biosciences 3.70 Bn 776.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.98 Mn
Mar 31, 2026 43.75 Mn
Dec 31, 2025 40.89 Mn
Sep 30, 2025 45.26 Mn
Jun 30, 2025 37.75 Mn
Mar 31, 2025 32.91 Mn
Dec 31, 2024 30.35 Mn
Sep 30, 2024 28.09 Mn
Jun 30, 2024 24.25 Mn
Mar 31, 2024 17.52 Mn
Dec 31, 2023 18.76 Mn
Sep 30, 2023 16.19 Mn
Jun 30, 2023 14.69 Mn
Mar 31, 2023 17.27 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 16.99 Mn
Jun 30, 2022 16.23 Mn
Mar 31, 2022 12.63 Mn
Dec 31, 2021 12.32 Mn
Sep 30, 2021 11.89 Mn
API Access

IDEAYA Biosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY